CytomX Therapeutics, Inc. (CTMX)
2.34
+0.05
(+2.18%)
USD |
NASDAQ |
Oct 30, 16:00
2.37
+0.03
(+1.28%)
After-Hours: 20:00
CytomX Therapeutics Market Cap : 509.88M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 509.88M |
| October 29, 2026 | 498.99M |
| October 28, 2026 | 514.24M |
| October 27, 2026 | 503.35M |
| October 26, 2026 | 484.83M |
| October 23, 2026 | 505.53M |
| October 22, 2026 | 531.67M |
| October 21, 2026 | 522.96M |
| October 20, 2026 | 546.93M |
| October 19, 2026 | 509.88M |
| October 16, 2026 | 496.81M |
| October 15, 2026 | 525.14M |
| October 14, 2026 | 485.92M |
| October 13, 2026 | 506.62M |
| October 12, 2026 | 527.32M |
| October 09, 2026 | 560.00M |
| October 08, 2026 | 538.21M |
| October 07, 2026 | 555.64M |
| October 06, 2026 | 557.82M |
| October 05, 2026 | 562.18M |
| October 02, 2026 | 557.82M |
| October 01, 2026 | 573.08M |
| September 30, 2026 | 592.69M |
| September 29, 2026 | 599.22M |
| September 28, 2026 | 586.15M |
| Date | Value |
|---|---|
| September 25, 2026 | 588.33M |
| September 24, 2026 | 599.22M |
| September 23, 2026 | 605.76M |
| September 22, 2026 | 640.62M |
| September 21, 2026 | 601.40M |
| September 18, 2026 | 601.40M |
| September 17, 2026 | 614.48M |
| September 16, 2026 | 602.49M |
| September 15, 2026 | 586.15M |
| September 14, 2026 | 697.28M |
| September 11, 2026 | 716.89M |
| September 10, 2026 | 729.96M |
| September 09, 2026 | 771.36M |
| September 08, 2026 | 795.33M |
| September 04, 2026 | 808.41M |
| September 03, 2026 | 801.87M |
| September 02, 2026 | 810.59M |
| September 01, 2026 | 799.69M |
| August 31, 2026 | 732.14M |
| August 28, 2026 | 699.46M |
| August 27, 2026 | 745.22M |
| August 26, 2026 | 723.43M |
| August 25, 2026 | 734.32M |
| August 24, 2026 | 716.89M |
| August 21, 2026 | 714.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 95.94B |
| ACADIA Pharmaceuticals, Inc. | 3.544B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 280.37M |
| Savara, Inc. | 990.03M |
Market Cap Related Metrics
| PS Ratio | 23.38 |
| Price to Book Value | 1.688 |
| Price | 2.34 |
| Earnings Yield | -19.53% |